Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

NKp30/NCR3 Antibody (012), HRP, Novus Biologicals™
SDP

Catalog No. NB108136 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB108136 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB108136 Supplier Novus Biologicals Supplier No. NBP289525H
Only null left
Add to Cart
Add to Cart

Rabbit Monoclonal Antibody

NKp30/NCR3 Monoclonal specifically detects NKp30/NCR3 in Human samples. It is validated for Western Blot, ELISA.

Specifications

Antigen NKp30/NCR3
Applications Western Blot, ELISA
Classification Monoclonal
Clone 12
Conjugate HRP
Formulation PBS
Gene Alias Activating natural killer receptor p30, CD337 antigen, CD337activating NK-A1 receptor, LY117,1C7NK-p30, lymphocyte antigen 117, natural cytotoxicity triggering receptor 3, Natural killer cell p30-related protein, NKP30, NKp30MALS
Host Species Rabbit
Immunogen This antibody was obtained from a rabbit immunized with purified, recombinant Human NKp30/NCR3 (NP_667341.1; Met1-Gly135).
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Adaptive Immunity, Checkpoint signaling, Immunology, Stem Cells
Primary or Secondary Primary
Gene ID (Entrez) 259197
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.